>>> US Research Calls

Research Calls

  • Upgrades:
    • Eversource Energy (ES) upgraded to Buy from Neutral at Guggenheim; tgt raised to $97
    • Howmet Aerospace (HWM) upgraded to Buy from Hold at The Benchmark Company; tgt $40
    • Interpublic (IPG) upgraded to Overweight from Equal Weight at Wells Fargo; tgt lowered to $33
    • Lennox Int'l (LII) upgraded to Outperform from Market Perform at Cowen; tgt $26
    • Omnicom (OMC) upgraded to Overweight from Equal Weight at Wells Fargo; tgt lowered to $73
    • The Vita Coco Company (COCO) upgraded to Buy from Neutral at BofA Securities; tgt raised to $12
    • Trane (TT) upgraded to Outperform from Market Perform at Cowen; tgt $18
    • XPO Logistics (XPO) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt $75
  • Downgrades:
    • Agilent (A) downgraded to Neutral from Buy at Citigroup; tgt lowered to $140
    • Audacy (AUD) downgraded to Underweight from Equal Weight at Wells Fargo
    • Clear Channel Outdoor (CCO) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $1.50
    • Huntington Banc (HBAN) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $13.50
    • iHeartMedia (IHRT) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $9
    • Illinois Tool (ITW) downgraded to Neutral from Buy at UBS; tgt lowered to $185
    • Kennametal (KMT) downgraded to Sell from Neutral at UBS; tgt lowered to $19
    • Madrigal Pharmaceuticals (MDGL) downgraded to Neutral from Buy at B. Riley Securities; tgt lowered to $75
    • PayPal (PYPL) downgraded to Neutral from Buy at Redburn
    • Peoples Bancorp (PEBO) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $30
    • Six Flags (SIX) downgraded to Neutral from Buy at Citigroup; tgt lowered to $26
    • Upstart (UPST) downgraded to Mkt Perform from Mkt Outperform at JMP Securities
    • Wipro (WIT) downgraded to Underperform from Hold at Jefferies; tgt lowered to $4.70
  • Others:
    • Blueprint Medicines (BPMC) initiated with an Outperform at Oppenheimer; tgt $80
    • DPCM Capital (XPOA) initiated with a Buy at The Benchmark Company; tgt $14
    • ImaRx Therapeutics (IMRX) initiated with a Buy at Chardan Capital Markets; tgt $18
    • Now (DNOW) initiated with a Buy at The Benchmark Company; tgt $13
    • Rocket Pharmaceuticals (RCKT) initiated with an Outperform at Raymond James; tgt $22
    • Vertex Energy (VTNR) initiated with an Outperform at Oppenheimer; tgt $18